Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Ballet

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Bioorganic Chemistry|May 21, 2023
Determination of structural features that underpin the pannexin1 channel inhibitory activity of the peptide <sup>10</sup>Panx1Anne Caufriez, Arthur Lamouroux, Charlotte Martin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2024
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogelsJulie Heremans, Robin Maximilian Awad, Jessica Bridoux, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2007
Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffoldSteven Ballet, Alexander V Mayorov, Minying Cai, et al.
Biomaterials Science|June 17, 2025
Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogelsHue Vu, Evelien Peeters, Kenneth Hofkens, et al.
International Journal of Molecular Sciences|May 28, 2022
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 ChannelsAnne Caufriez, Andrés Tabernilla, Raf Van Campenhout, et al.
Nature Communications|November 16, 2017
Antimicrobial peptides in frog poisons constitute a molecular toxin delivery system against predatorsConstantijn Raaymakers, Elin Verbrugghe, Sophie Hernot, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Synthesis and <i>in Vitro</i> Evaluation of Stabilized and Selective Neuromedin U-1 Receptor AgonistsAn De Prins, Charlotte Martin, Yannick Van Wanseele, et al.
Nucleic Acids Research|March 3, 2023
YbiB: a novel interactor of the GTPase ObgEBabette Deckers, Silke Vercauteren, Veerke De Kock, et al.
Nature Communications|October 9, 2024
Structural basis of μ-opioid receptor targeting by a nanobody antagonistJun Yu, Amit Kumar, Xuefeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2021
Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stabilityDirk Tourwé, Antonis D Tsiailanis, Nikolaos Parisis, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Bioorganic Chemistry|May 21, 2023
Determination of structural features that underpin the pannexin1 channel inhibitory activity of the peptide <sup>10</sup>Panx1Anne Caufriez, Arthur Lamouroux, Charlotte Martin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2024
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogelsJulie Heremans, Robin Maximilian Awad, Jessica Bridoux, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2007
Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffoldSteven Ballet, Alexander V Mayorov, Minying Cai, et al.
Biomaterials Science|June 17, 2025
Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogelsHue Vu, Evelien Peeters, Kenneth Hofkens, et al.
International Journal of Molecular Sciences|May 28, 2022
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 ChannelsAnne Caufriez, Andrés Tabernilla, Raf Van Campenhout, et al.
Nature Communications|November 16, 2017
Antimicrobial peptides in frog poisons constitute a molecular toxin delivery system against predatorsConstantijn Raaymakers, Elin Verbrugghe, Sophie Hernot, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Synthesis and <i>in Vitro</i> Evaluation of Stabilized and Selective Neuromedin U-1 Receptor AgonistsAn De Prins, Charlotte Martin, Yannick Van Wanseele, et al.
Nucleic Acids Research|March 3, 2023
YbiB: a novel interactor of the GTPase ObgEBabette Deckers, Silke Vercauteren, Veerke De Kock, et al.
Nature Communications|October 9, 2024
Structural basis of μ-opioid receptor targeting by a nanobody antagonistJun Yu, Amit Kumar, Xuefeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2021
Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stabilityDirk Tourwé, Antonis D Tsiailanis, Nikolaos Parisis, et al.
Pageof 15